These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16696576)

  • 1. Role of melatonin in the pathophysiology of migraine: implications for treatment.
    Vogler B; Rapoport AM; Tepper SJ; Sheftell F; Bigal ME
    CNS Drugs; 2006; 20(5):343-50. PubMed ID: 16696576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current understanding of pineal gland structure and function in headache.
    Peres MF; Valença MM; Amaral FG; Cipolla-Neto J
    Cephalalgia; 2019 Nov; 39(13):1700-1709. PubMed ID: 31370669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic potential of melatonin in migraines and other headache types.
    Gagnier JJ
    Altern Med Rev; 2001 Aug; 6(4):383-9. PubMed ID: 11578254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of melatonin on gene expression of calcitonin gene-related peptide and some proinflammatory mediators in patients with pure menstrual migraine.
    Ansari M; Karkhaneh A; Kheirollahi A; Emamgholipour S; Rafiee MH
    Acta Neurol Belg; 2017 Sep; 117(3):677-685. PubMed ID: 28584969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pathogenetic Role of Melatonin in Migraine and Its Theoretic Implications for Pharmacotherapy: A Brief Overview of the Research.
    Zduńska A; Cegielska J; Domitrz I
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of the pineal gland on migraine and cluster headaches and effects of treatment with picoTesla magnetic fields.
    Sandyk R
    Int J Neurosci; 1992; 67(1-4):145-71. PubMed ID: 1305631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New aspects of neurobiology of migraine: the role of hypothalamic-pineal system].
    Tabeeva GR; Sergeev AV; Gromova SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(8 Pt 1):79-85. PubMed ID: 22148139
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypothalamic involvement in chronic migraine.
    Peres MF; Sanchez del Rio M; Seabra ML; Tufik S; Abucham J; Cipolla-Neto J; Silberstein SD; Zukerman E
    J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):747-51. PubMed ID: 11723194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lack of vasoconstrictor effect of the pineal hormone melatonin in an animal model predictive of antimigraine activity.
    Tom B; De Vries P; Heiligers JP; Willems EW; Scalbert E; Delagrange P; Saxena PR
    Cephalalgia; 2001 Jul; 21(6):656-63. PubMed ID: 11531897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin: a significant contributor to the pathogenesis of migraine.
    Toglia JU
    Med Hypotheses; 2001 Oct; 57(4):432-4. PubMed ID: 11601864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
    Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
    Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential therapeutic use of melatonin in migraine and other headache disorders.
    Peres MF; Masruha MR; Zukerman E; Moreira-Filho CA; Cavalheiro EA
    Expert Opin Investig Drugs; 2006 Apr; 15(4):367-75. PubMed ID: 16548786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects of the clinical utilization of melatonin.
    Bubenik GA; Blask DE; Brown GM; Maestroni GJ; Pang SF; Reiter RJ; Viswanathan M; Zisapel N
    Biol Signals Recept; 1998; 7(4):195-219. PubMed ID: 9730580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep quality, morningness-eveningness preference, mood profile, and levels of serum melatonin in migraine patients: a case-control study.
    Kozak HH; Boysan M; Uca AU; Aydın A; Kılınç İ; Genç E; Altaş M; Güngör DC; Turgut K; Özer N
    Acta Neurol Belg; 2017 Mar; 117(1):111-119. PubMed ID: 27858294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic mechanisms of migraine and its acute treatment.
    Edvinsson L; Villalón CM; MaassenVanDenBrink A
    Pharmacol Ther; 2012 Dec; 136(3):319-33. PubMed ID: 22939884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-1 inhibits nitroglycerin-induced trigeminal activation of oxidative stress, calcitonin gene-related peptide and c-Fos expression.
    Won L; Kraig RP
    Neurosci Lett; 2021 Apr; 751():135809. PubMed ID: 33713748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine.
    Messlinger K; Fischer MJ; Lennerz JK
    Keio J Med; 2011; 60(3):82-9. PubMed ID: 21979827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the suprachiasmatic nucleus in the pathogenesis of migraine attacks.
    Zurak N
    Cephalalgia; 1997 Nov; 17(7):723-8. PubMed ID: 9399000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcitonin gene-related peptide (CGRP) and migraine.
    Durham PL
    Headache; 2006 Jun; 46 Suppl 1(Suppl 1):S3-8. PubMed ID: 16927957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcitonin gene-related peptide and its role in migraine pathophysiology.
    Arulmani U; Maassenvandenbrink A; Villalón CM; Saxena PR
    Eur J Pharmacol; 2004 Oct; 500(1-3):315-30. PubMed ID: 15464043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.